The Brazil Hematology market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Hematology is a medical science branch concerned with diagnosing, treating, and studying blood and disorders associated with blood. It includes treating blood disorders such as leukaemia, malignancies, and kinds of haemophilia, sickle-cell anaemia, and lymphoma.
Major factors responsible for market growth are increasing prevalence of blood-related disorders, rising use of automated instruments in hematology field.
Rising research and development expenditure by private investors and SUS policies, increasing use of flow cytometry in hematology testing are some other factors driving the growth of the market.
Whereas, slow adoption of the advanced hematology instruments and high cost are hindering the market’s growth.